Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han-Chen Chiu

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecules (Basel, Switzerland)|June 20, 2014
Magnetic Pycnoporus sanguineus-loaded alginate composite beads for removing dye from aqueous solutionsChih-Hui Yang, Ming-Cheng Shih, Han-Chen Chiu, et al.
Plos One|March 28, 2014
High-throughput quantitative proteomic analysis of dengue virus type 2 infected A549 cellsHan-Chen Chiu, Holger Hannemann, Kate J Heesom, et al.
The Journal of Biological Chemistry|June 18, 2013
Serotype-specific differences in dengue virus non-structural protein 5 nuclear localizationHolger Hannemann, Po-Yu Sung, Han-Chen Chiu, et al.
The Journal of Clinical Investigation|March 22, 2022
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variantsChang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecules (Basel, Switzerland)|June 20, 2014
Magnetic Pycnoporus sanguineus-loaded alginate composite beads for removing dye from aqueous solutionsChih-Hui Yang, Ming-Cheng Shih, Han-Chen Chiu, et al.
Plos One|March 28, 2014
High-throughput quantitative proteomic analysis of dengue virus type 2 infected A549 cellsHan-Chen Chiu, Holger Hannemann, Kate J Heesom, et al.
The Journal of Biological Chemistry|June 18, 2013
Serotype-specific differences in dengue virus non-structural protein 5 nuclear localizationHolger Hannemann, Po-Yu Sung, Han-Chen Chiu, et al.
The Journal of Clinical Investigation|March 22, 2022
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variantsChang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, et al.
Pageof 1